In Vivo Gene Therapy via Receptor-Mediated DNA Delivery

  • Henry C. Chiou
  • George L. Spitalny
  • June R. Merwin
  • Mark A. Findeis


Human gene therapy has advanced during the past ten years from a theoretical concept to a rapidly emerging technology. Tremendous technological strides in recombinant DNA methodologies have fostered molecular studies in such fields as regulation of gene expression, human genetics and disease states, and gene transfer techniques. The confluence of these fields has led to the emergence of gene therapy as a reality, albeit limited at present to a small number of clinical studies (Anderson, 1992; Miller, 1992). As practiced today most gene therapy protocols lie within the realm of high-cost, technology-intensive, individualized treatments, akin to such procedures as organ and bone marrow transplantation (Mulligan, 1991). This type of procedure, though beneficial, is limited in usefulness since it is not readily accessible to much of the population. Even for those to whom this type of gene therapy strategy would be available, the current inability to achieve permanent transgene expression necessitates periodic retreatments, making these procedures highly cost-ineffective over the long term.


Gene Therapy Gene Transfer Gene Delivery Cystic Fibrosis Transmembrane Conductance Regulator Asialoglycoprotein Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson WF (1992): Human gene therapy. Science 256: 808–813PubMedCrossRefGoogle Scholar
  2. Arnon R, Sela M (1982): In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies. Immunol Rev 62: 5–27PubMedCrossRefGoogle Scholar
  3. Ash well G, Harford J (1982): Carbohydrate-specific receptors of the liver. Ann Rev Biochem 51: 531–554CrossRefGoogle Scholar
  4. Ashwell G, Morell AG (1974): The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 44: 99–129Google Scholar
  5. Baümler E (1984): Paul Ehrlich, Scientist for Life. New York: Holmes & Meier p. 108Google Scholar
  6. Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS (1990): Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing. Cancer Res 50: 6608–6614PubMedGoogle Scholar
  7. Chowdhury JR, Hays RM, Wu CH, Bommanani VR, Yemeni PC, Mukhopadhyay B, Wu GY, Chowdhury NR (1993): Disruption of microtubules results in prolonged persistence and expression of genes targeted to the liver in vivo by receptor-mediated endocytosis. Gastroenterology 104: A981Google Scholar
  8. Cotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H, Birnstiel ML (1990): Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of trasnfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 87: 4033–4037PubMedCrossRefGoogle Scholar
  9. Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML (1992): High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci USA 89: 6094–6098PubMedCrossRefGoogle Scholar
  10. Cristiano RJ, Smith LC, Woo SLC (1993): Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary heaptocytes. Proc Natl Acad Sci USA 90: 2122–2126PubMedCrossRefGoogle Scholar
  11. Curiel DT, Agarwal S, Wagner E, Cotten M (1991): Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 88: 8850–8854PubMedCrossRefGoogle Scholar
  12. Ewel CH, Urba WJ, Kopp WC, Smith JW, Steis RG, Rossio JL, Longo DL, Jones MJ, Alvord WG, Pinsky CM, Beveridge JM, McNitt KL, Creekmore SP (1992): Polyinosinic-polycytidylic acid complexed with poly-L-lysine and car- boxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res 52: 3005–3010PubMedGoogle Scholar
  13. Feigner PL (1993): Genes in a bottle. Lab Invest 68: 1–3Google Scholar
  14. Findeis MA, Merwin JR, Spitalny GL, Chiou HC (1993): Targeted delivery of DNA for gene therapy via receptors. Trends Biotechnol 11: 202–205PubMedCrossRefGoogle Scholar
  15. Freeman AI, Mayhew E (1986): Targeted drug delivery. Cancer 58: 573–583PubMedCrossRefGoogle Scholar
  16. Guyton AC (1981): Medical Physiology, Philadelphia: W.B. Saunders Company, p. 875Google Scholar
  17. Hartmann D, Schneider MA, Lenz BF, Talmadge JE (1987): Toxicity of polyinosinic-polycytidylic acid admixed with poly-L-lysine and solubilized with carboxymethylcellulose in mice. Pathol Immunopathol Res 6: 37–50PubMedCrossRefGoogle Scholar
  18. Homewood CA, Warhurst DC, Peters W, Baggaley VC (1972): Lysosomes, pH and the antimalarial action of chloroquine. Nature 235: 50–52PubMedCrossRefGoogle Scholar
  19. Lampkin BC, Levine AS, Levy H, Krivit W, Hammond D (1985): Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children’s Cancer Study Group. Cancer Res 45: 5904–5909PubMedGoogle Scholar
  20. Lee RT, Lee YC (1987): Preparation of cluster glycosides of N-acetylgalactosamine that have subnanomolar binding constants towards the mammalian hepatic Gal/GalNAc-specific receptor. Glycoconjugate J 4: 317–328CrossRefGoogle Scholar
  21. Michael SI, Huang C-H, Romer MU, Wagner E, Hu P-C, Curiel DT (1993): Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. J Biol Chem 268: 6866–6869PubMedGoogle Scholar
  22. Miller AD (1992): Human gene therapy comes of age. Nature 357: 455–460PubMedCrossRefGoogle Scholar
  23. Mulligan RC (1991): Gene transfer and gene therapy: principles, prospects, and perspective. In: Etiology of Human Disease at the DNA Level, Lindsten J, Pettersson U, eds. New York: Raven Press, pp 143–189Google Scholar
  24. Mulligan RC (1993): The basic science of gene therapy. Science 260: 926–932PubMedCrossRefGoogle Scholar
  25. Neda H, Wu CH, Wu GY (1991): Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J Biol Chem 266: 14143–14146PubMedGoogle Scholar
  26. Ochsner M, Creba J, Walker J, Bentley P, Muakkassah-Kelly SF (1990): Nafenopin, a hypolipidemic and non-genotoxic hepatocarcinogen increases intracellular calcium and transiently decreases intracellular pH in hepatocytes without generation of inositol phosphates. Biochem Pharmacol 40: 2247–2257PubMedCrossRefGoogle Scholar
  27. Orton TC, and Parker GL (1982): The effect of hypolipidemic agents on the hepatic microsomal enzyme systems in the rat. Drug Metab Dis 10: 110–115Google Scholar
  28. Pastan I, Chaudhary V, FitzGerald DJP (1992): Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61: 331–354PubMedCrossRefGoogle Scholar
  29. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E (1992): Gene transfer into hepatocytes using asioaloglycoprotein receptor mediated endocytosis of dna complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem 3: 533–539CrossRefGoogle Scholar
  30. Rappaport AM (1987): In: Diseases of the Liver, Schiff L, Schiff ER, eds. Philadelphia: J.B. Lippincott Co., p. 22Google Scholar
  31. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, Pavirani A, Lecocq J-P, Crystal RG (1992): In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143–155PubMedCrossRefGoogle Scholar
  32. Schmid K (1975): In The Plasma Proteins, Structure, Function, and Genetic Control. 2nd edition. Putnam FW, ed. New York: Academic Press. Chapter 4Google Scholar
  33. Schmid K, Polis A, Hunziker K, Fricke R, Yayoshi M (1967): Partial characterization of the sialic acid-free forms of aracid glycoprotein from human plasma. Biochem J 104: 361–368PubMedGoogle Scholar
  34. Schwartz AL (1984): The hepatic asialoglycoprotein receptor. CRC Crit Rev Biochem 16: 207–233PubMedCrossRefGoogle Scholar
  35. Schwartz AL (1991): Trafficking of asialoglycoproteins and the asialoglycoprotein receptor. In: Liver Diseases: Targeted Diagnosis and Therapy Using Specific Receptors and Ligands, Wu GY, Wu CH, eds. New York: Marcel Dekker, Inc. pp. 3–39Google Scholar
  36. Soriano P, Dijkstra J, Legrand A, Spanjer H, Londos-Gagliardi D, Roerdink F, Scherphof G, Nicolau C (1983): Targeted and non-targeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene. Proc Natl Acad Sci USA 80: 7128–7131PubMedCrossRefGoogle Scholar
  37. Spiess M (1990): The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 29: 10009–10018PubMedCrossRefGoogle Scholar
  38. Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R (1992): Aerosol gene delivery in vivo. Proc Natl Acad Sci USA 89: 11277–11281PubMedCrossRefGoogle Scholar
  39. Thompson L (1992): At age 2, gene therapy enters a growth phase. Science 258: 744–746PubMedCrossRefGoogle Scholar
  40. Vitetta ES (1990): Immunotoxins: New therapeutic reagents for autoimmunity, cancer, and AIDS. J Clin Immunol 10: 15S–18SPubMedCrossRefGoogle Scholar
  41. Wagner E, Cotten M, Foisner R, Birnstiel ML (1991): Transferrin-polycation-DNA complexes: the effect of poly cations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA 88: 4255–4259PubMedCrossRefGoogle Scholar
  42. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML (1992b): Influenza virus hemaglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrinpolylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 89: 7934–7938PubMedCrossRefGoogle Scholar
  43. Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler C, Curiel DT, Birnstiel ML (1992a): Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89: 6099–6103PubMedCrossRefGoogle Scholar
  44. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML (1990): Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 87: 3410–3414PubMedCrossRefGoogle Scholar
  45. Whitehead PH, Sammons HG (1966): A simple technique for the isolation of orosomucoid from normal and pathological sera. Biochim Biophys Acta 124: 209–211PubMedCrossRefGoogle Scholar
  46. Wilson JM, Grossman M, Wu CH, Chowdhury NR, Wu GY, Chowdhury JR (1992): Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J Biol Chem 267: 963–967PubMedGoogle Scholar
  47. Wong, SS (1993): Chemistry of Protein Conjugation and Cross-Linking. Boca Raton: CRC PressGoogle Scholar
  48. Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH (1991): Receptor-mediated gene delivery in vivo: Partial correction of genetic analbuminemia in Nagase rats. J Biol Chem 266: 14338–14342PubMedGoogle Scholar
  49. Wu CH, Wilson JM, Wu GY (1989): Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem 264: 16985–16987PubMedGoogle Scholar
  50. Wu GY, Tangco MV, Wu CH (1990): Targeted gene delivery: persistence of foreign gene expression achieved by pharmacological means. Hepatology 12: 871CrossRefGoogle Scholar
  51. Wu GY, Wu CH (1987): Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262: 4429–4432PubMedGoogle Scholar
  52. Wu GY, Wu CH (1988a): Receptor-mediated gene delivery and expression in vivo. J Biol Chem 263: 14621–14624PubMedGoogle Scholar
  53. Wu GY, Wu CH (1988b): Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry 27: 887–892PubMedCrossRefGoogle Scholar
  54. Wu GY, Wu CH (1992): Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem 267: 12436–12439PubMedGoogle Scholar
  55. Wu GW, Zhan P, Rowell DL, Wu CH (1992): Modification of inactivated adenovirus with a targetable DNA carrier enhances foreign gene expression in vitro and in vivo. Hepatology 16: 112AGoogle Scholar
  56. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML (1990): Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA 87: 3655–3659PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1994

Authors and Affiliations

  • Henry C. Chiou
  • George L. Spitalny
  • June R. Merwin
  • Mark A. Findeis

There are no affiliations available

Personalised recommendations